Found: 43
Select item for more details and to access through your institution.
Endovascular Infection with Kingella kingae Complicated by Septic Arthritis in Immunocompromised Adult Patient.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Transthoracic parametric Doppler for bedside diagnosis of pulmonary embolism: A pilot study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The ubiquitin ligase RNF5 determines acute myeloid leukemia growth and susceptibility to histone deacetylase inhibitors.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-25664-7
- By:
- Publication type:
- Article
Gilteritinib with or without venetoclax for relapsed/refractory FLT3‐mutated acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 932, doi. 10.1111/bjh.19548
- By:
- Publication type:
- Article
The increasingly blurred line between induction, consolidation and maintenance in acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 5, p. 556, doi. 10.1111/bjh.18613
- By:
- Publication type:
- Article
How we treat older patients with acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2020, v. 191, n. 5, p. 682, doi. 10.1111/bjh.16701
- By:
- Publication type:
- Article
Anti‐thymocyte globulin for graft‐versus‐host disease prophylaxis in patients with intermediate‐ or high‐risk acute myeloid leukaemia undergoing reduced‐intensity conditioning allogeneic stem cell transplantation in first complete remission – a survey on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 4, p. 643, doi. 10.1111/bjh.15131
- By:
- Publication type:
- Article
Use of CYP3Ai and impact on outcomes in patients with acute myeloid leukemia treated with venetoclax plus azacitidine in the VIALE‐A study.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. E422, doi. 10.1002/ajh.26707
- By:
- Publication type:
- Article
Timing of response with venetoclax combination treatment in patients with newly diagnosed acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 8, p. E299, doi. 10.1002/ajh.26600
- By:
- Publication type:
- Article
Venetoclax combinations induce high response rates in newly diagnosed acute myeloid leukemia patients ineligible for intensive chemotherapy in routine practice.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 7, p. 790, doi. 10.1002/ajh.26190
- By:
- Publication type:
- Article
Patterns of Information-Seeking for Cancer on the Internet: An Analysis of Real World Data.
- Published in:
- PLoS ONE, 2012, v. 7, n. 9, p. 1, doi. 10.1371/journal.pone.0045921
- By:
- Publication type:
- Article
Correction to: Gilteritinib monotherapy for relapsed/refractory FLT3 mutated acute myeloid leukemia: a real‑world, multi‑center, matched analysis.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Gilteritinib monotherapy for relapsed/refractory FLT3 mutated acute myeloid leukemia: a real-world, multi-center, matched analysis.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 9, p. 2001, doi. 10.1007/s00277-022-04895-8
- By:
- Publication type:
- Article
Venetoclax in combination with FLAG-IDA-based protocol for patients with acute myeloid leukemia: a real-world analysis.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 8, p. 1719, doi. 10.1007/s00277-022-04883-y
- By:
- Publication type:
- Article
Safety and efficacy of blinatumomab: a real world data.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Midostaurin in combination with intensive chemotherapy is safe and associated with improved remission rates and higher transplantation rates in first remission-a multi-center historical control study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Second line azacitidine for elderly or infirmed patients with acute myeloid leukemia (AML) not eligible for allogeneic hematopoietic cell transplantation-a retrospective national multicenter study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Azacitidine-lenalidomide (ViLen) combination yields a high response rate in higher risk myelodysplastic syndromes (MDS)-ViLen-01 protocol.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Compromised activity of natural killer cells in diffuse large b-cell lymphoma is related to lymphoma-induced modification of their surface receptor expression.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 3, p. 707, doi. 10.1007/s00262-022-03284-4
- By:
- Publication type:
- Article
Venetoclax‐based salvage therapy for adult patients with relapsed/refractory acute lymphoblastic leukemia.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 3, p. 365, doi. 10.1111/ejh.14015
- By:
- Publication type:
- Article
Midostaurin in combination with chemotherapy is most effective in patients with acute myeloid leukemia presenting with high FLT3‐ITD allelic ratio who proceed to allogeneic stem cell transplantation while in first complete remission.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 1, p. 64, doi. 10.1111/ejh.13518
- By:
- Publication type:
- Article
Deciphering molecular mechanisms underlying chemoresistance in relapsed AML patients: towards precision medicine overcoming drug resistance.
- Published in:
- Cancer Cell International, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12935-021-01746-w
- By:
- Publication type:
- Article
ERK Activity in Immature Leukemic Cells Drives Clonal Selection during Induction Therapy for Acute Myeloid Leukemia.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-65061-6
- By:
- Publication type:
- Article
To be a doctor in Jerusalem: life under threat of terrorism.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Spontaneous arising of a lymphoblastoid B‐cell line harbouring a pre‐leukemic DNMT3A mutation in acute myeloid leukaemia cell culture.
- Published in:
- Journal of Cellular & Molecular Medicine, 2021, v. 25, n. 22, p. 10778, doi. 10.1111/jcmm.16992
- By:
- Publication type:
- Article
Efficacy and Safety Profile of Ivosidenib in the Management of Patients with Acute Myeloid Leukemia (AML): An Update on the Emerging Evidence.
- Published in:
- Blood & Lymphatic Cancer: Targets & Therapy, 2021, v. 11, p. 41, doi. 10.2147/BLCTT.S236446
- By:
- Publication type:
- Article
Midostaurin in Combination with Intensive Chemotherapy is Safe and Associated with Improved Remission Rates and Higher Transplantation Rates in First Remission-A Multi-Center Historical Control Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S208, doi. 10.1016/j.clml.2019.07.072
- By:
- Publication type:
- Article
Final Phase IIa Study Results Evaluating the CXCR4 Antagonist BL-8040 in Combination with Cytarabine (Ara-C) for the Treatment of Relapsed/Refractory AML Patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S28, doi. 10.1016/j.clml.2016.07.040
- By:
- Publication type:
- Article
Higher infection rate after 7- compared with 5-day cycle of azacitidine in patients with higher-risk myelodysplastic syndrome.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Baseline Chest Computed Tomography for Early Diagnosis of Invasive Pulmonary Aspergillosis in Hemato-oncological Patients: A Prospective Cohort Study.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 10, p. 1805, doi. 10.1093/cid/ciz194
- By:
- Publication type:
- Article
Near-Fatal Amitraz Intoxication: The Overlooked Pesticide.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2005, v. 97, n. 3, p. 185, doi. 10.1111/j.1742-7843.2005.pto_97399.x
- By:
- Publication type:
- Article
Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 4, p. 1, doi. 10.1038/s41408-022-00668-8
- By:
- Publication type:
- Article
Bone marrow blast elimination by the fifth day of 7 + 3 induction is the strongest predictor of potential cure in patients with acute myeloid leukemia younger than 61 years of age: A long‐term follow‐up of a multi‐center prospective study
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 1, p. E3, doi. 10.1002/ajh.25651
- By:
- Publication type:
- Article
Prospective comparison of early bone marrow evaluation on day 5 versus day 14 of the "3+7" induction regimen for acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 12, p. 1159, doi. 10.1002/ajh.24207
- By:
- Publication type:
- Article
Allogeneic stem cell transplantation for patients with chronic myeloid leukemia: Risk stratified approach with a long-term follow-up.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 9, p. 875, doi. 10.1002/ajh.23263
- By:
- Publication type:
- Article
Genetic profiling in acute myeloid leukaemia ─ where are we and what is its role in patient management.
- Published in:
- British Journal of Haematology, 2013, v. 160, n. 3, p. 303, doi. 10.1111/bjh.12135
- By:
- Publication type:
- Article
Antitumoral effects of cannabis in Notch1‐mutated T‐cell acute lymphoblastic leukemia.
- Published in:
- Cancer Communications, 2023, v. 43, n. 6, p. 711, doi. 10.1002/cac2.12422
- By:
- Publication type:
- Article
The Effect of Oral Iron Chelator Deferiprone on Iron Overload and Oxidative Stress in Patients with Myelodysplastic Syndromes: A Study by the Israeli MDS Working Group.
- Published in:
- Acta Haematologica, 2024, v. 147, n. 4, p. 427, doi. 10.1159/000535749
- By:
- Publication type:
- Article
Acute Myeloid Leukemia in Adolescents and Young Adults: Challenging Aspects.
- Published in:
- Acta Haematologica, 2014, v. 132, n. 3/4, p. 292, doi. 10.1159/000360200
- By:
- Publication type:
- Article
The role of specialized hospital units in infection and mortality risk reduction among patients with hematological cancers.
- Published in:
- PLoS ONE, 2019, v. 14, n. 3, p. 1, doi. 10.1371/journal.pone.0211694
- By:
- Publication type:
- Article
BL‐8040 CXCR4 antagonist is safe and demonstrates antileukemic activity in combination with cytarabine for the treatment of relapsed/refractory acute myelogenous leukemia: An open‐label safety and efficacy phase 2a study.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 8, p. 1246, doi. 10.1002/cncr.33338
- By:
- Publication type:
- Article
Mortality burden related to infection with carbapenem-resistant Gram-negative bacteria among haematological cancer patients: a retrospective cohort study.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Genetic Stratification in Myeloid Diseases: From Risk Assessment to Clinical Decision Support Tool.
- Published in:
- Rambam Maimonides Medical Journal, 2014, v. 5, n. 4, p. 1, doi. 10.5041/RMMJ.10159
- By:
- Publication type:
- Article